Related Experiment Video
Updated: Mar 11, 2026

Preparation of a Blood Culture Pellet for Rapid Bacterial Identification and Antibiotic Susceptibility Testing
Published on: October 15, 2014
Patterns and trends of pediatric bloodstream infections: a 7-year surveillance study
N Buetti1, A Atkinson2, L Kottanattu2
1Department of Infectious Diseases, University Hospital Bern, Freiburgstrasse 3010, Bern, Switzerland. niccolo.buetti@gmail.com.
Insights
Pediatric bloodstream infections in Switzerland are primarily caused by Staphylococcus aureus and Escherichia coli, with consistently low resistance rates. Coagulase-negative staphylococci (CoNS) bloodstream infections increased significantly, while pneumococcal infections decreased, likely due to vaccination.
Area of Science:
- Epidemiology
- Infectious Diseases
- Pediatrics
- Antimicrobial Resistance
Background:
- Pediatric bloodstream infections (BSIs) represent a significant global health concern.
- Understanding regional pathogen distribution and antimicrobial resistance patterns is crucial for effective treatment and public health strategies.
- Switzerland's specific epidemiological landscape for pediatric BSIs requires detailed characterization.
Purpose of the Study:
- To characterize the epidemiology of pediatric bloodstream infections (BSIs) in Switzerland.
- To analyze pathogen distribution and antimicrobial resistance patterns in pediatric BSIs from 2008 to 2014.
- To compare pathogens and resistance trends across multiple acute care hospitals.
Main Methods:
- Analysis of data from the Swiss Antibiotic Resistance Surveillance (ANRESIS) database.
- Inclusion of 3,067 bacteremia episodes, with 1,823 confirmed as true BSIs.
- Statistical analysis comparing pathogens and resistance patterns in monomicrobial and polymicrobial BSIs across 20 acute care hospitals.
Main Results:
- Staphylococcus aureus (16.5%) and Escherichia coli (15.1%) were the most frequent pathogens.
- Coagulase-negative staphylococci (CoNS) BSIs increased by 50% from 2008 to 2014 (p=0.03).
- Streptococcus pneumoniae BSIs decreased significantly (p=0.007), coinciding with the introduction of the 13-valent conjugate vaccine.
Conclusions:
- Staphylococcus aureus and Escherichia coli remain the dominant pathogens in Swiss pediatric BSIs, with low resistance rates.
- A notable increase in CoNS BSIs was observed over the study period.
- The decline in S. pneumoniae BSIs is likely attributable to widespread pneumococcal conjugate vaccination.
Abstract:
We characterize the epidemiology of pediatric bloodstream infections (BSIs) in Switzerland. We analyzed pathogen distribution and resistance patterns in monomicrobial and polymicrobial BSIs in children from 2008 to 2014 using data from the Swiss antibiotic resistance centre (ANRESIS). A confirmatory statistical analysis was performed comparing pathogens and resistance across 20 acute care hospitals. We identified 3,067 bacteremia episodes, of which 1,823 (59 %) were considered true BSI episodes. Overall, S. aureus (16.5 %, 300) was the most frequent pathogen, followed by E. coli (15.1 %, 276), coagulase-negative staphylococci (CoNS, 12.9 %, 235), S. pneumoniae (11.1 %, 202) and non-E. coli Enterobacteriaceae (8.7 %, 159). S. aureus and E. coli showed similar frequencies in all of the variables analyzed (e.g., hospital acquisition, hospital type, medical specialty). The proportion of these microorganisms did not change over time, resistance rates remained low (4.3 % methicillin resistance in S. aureus; 7.3 % third-/fourth-generation cephalosporin resistance in E. coli), and no significant resistance trends were observed. We observed a 50 % increase of CoNS BSIs from 2008 (9.8 %, 27) to 2014 (15.2 %, 46, p value for trend = 0.03). S. pneumoniae decreased from 17.5 % (48) to 6.6 % (20) during that timeframe (p for trend = 0.007). S. aureus and E. coli remained the most significant pathogens among pediatric BSIs in Switzerland, exhibiting low resistance rates. CoNS accounted for a greater proportion of BSIs over time. The decrease in bacteremic pneumococcal infections can likely be attributed to the introduction of the 13-valent conjugate vaccine in 2011.
More Related Videos
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

